Int. J. Mol. Sci. 2013, 14(1), 1278-1292; doi:10.3390/ijms14011278

ANRIL: Molecular Mechanisms and Implications in Human Health

email, * email, email and email
Received: 6 November 2012; in revised form: 28 December 2012 / Accepted: 4 January 2013 / Published: 10 January 2013
(This article belongs to the Special Issue Non-Coding RNAs)
View Full-Text   |   Download PDF [448 KB, updated 19 June 2014; original version uploaded 19 June 2014]
Abstract: ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions. ANRIL has been shown to regulate its neighbor tumor suppressors CDKN2A/B by epigenetic mechanisms and thereby regulate cell proliferation and senescence. However, the clear role of ANRIL in the pathogenesis of these conditions is yet to be understood. Here, we review the recent findings on ANRIL molecular characterization and function, with a particular focus on its implications in human disease.
Keywords: ANRIL; CDKN2BAS; polycomb proteins; 9p21
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Congrains, A.; Kamide, K.; Ohishi, M.; Rakugi, H. ANRIL: Molecular Mechanisms and Implications in Human Health. Int. J. Mol. Sci. 2013, 14, 1278-1292.

AMA Style

Congrains A, Kamide K, Ohishi M, Rakugi H. ANRIL: Molecular Mechanisms and Implications in Human Health. International Journal of Molecular Sciences. 2013; 14(1):1278-1292.

Chicago/Turabian Style

Congrains, Ada; Kamide, Kei; Ohishi, Mitsuru; Rakugi, Hiromi. 2013. "ANRIL: Molecular Mechanisms and Implications in Human Health." Int. J. Mol. Sci. 14, no. 1: 1278-1292.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert